Benchtalk Volume 4: Life Science in the Time of COVID-19
Welcome to Benchtalk, a journal produced by Benchling. At Benchling, our mission is to accelerate life sciences for the benefit of humanity. As part of that mission, Benchling strives to engage the life sciences community in meaningful discussion and cross-discipline dialogue about the extraordinary goals of the field so that, together, we can work toward a better future. The quarterly Benchtalk Journal showcases the groundbreaking work of brilliant life scientists from academia to industry, facilitates discourse among members of the life sciences community, and connects them to revolutionary ideas.
This season, Benchtalk focuses on the impact that the COVID-19 pandemic has had on the field of life sciences, and the incredible response of the life science community to combat the virus. In this volume, we showcase life science R&D’s tireless work to bring tests, treatments, and vaccines to the public, as well as stories of how companies and labs are adjusting to these unprecedented circumstances.
Benchtalk features four categories of content:
- Spotlight showcases the lives and stories of life sciences community members, from scientists, to labs, to companies.
- Research includes articles written by Benchling users about their own exciting projects.
- Biotech features pieces about the state of the life sciences industry and how it will change the world as we know it.
- And last but not least, Benchling features announcements and updates about all things Benchling.
We post pieces of content to Benchtalk on a weekly basis and publish full volumes of Benchtalk on a quarterly basis, both in digital and print formats.
If you or someone you know is interested in being featured in Benchtalk, please email benchtalk@benchling.com
